Cantor Fitzgerald initiated coverage on Artiva Biotherapeutics with a new price target

8/13/24 7:23:42 AM ET

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

Cantor Fitzgerald initiated coverage of Artiva Biotherapeutics with a rating of Overweight and set a new price target of $23.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$ARTV

Date	Price Target	Rating	Analyst
6/11/2025	$12.00	Buy	H.C. Wainwright
12/30/2024	$20.00	Buy	H.C. Wainwright
8/13/2024	$21.00	Buy	Jefferies
8/13/2024	$23.00	Overweight	Cantor Fitzgerald
8/13/2024		Buy	TD Cowen
8/13/2024	$18.00	Outperform	Wedbush
8/13/2024	$23.00	Buy	Needham